In contrast to RA, autoimmune conditions such as type 1 diabetes, multiple sclerosis, and systemic lupus erythematosus utilize the pyruvate kinase-dependent hyperproduction of lactate to meet their energy demands and could experimentally be improved with the inhibition of PFKFB3.67 This evidence concerns the gene PFKFB3 and multiple sclerosis.